Pharma - HealthQuill

Cipla, Novartis team up to make, market anti-diabetic drug

HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.

by HealthQuill
April 10, 2023
0 Comments

Larsen and Toubro, one of the world’s top construction companies, got an order worth up to INR 25 billion ($305 million) to set up two plants in northern India.

Climate Health Pharma

India’s L&T bags hydrocarbon order worth up to $305 million

HQ Team April 10, 2023: Larsen and Toubro, one of the world’s top construction companies, got an order worth up to INR 25.

by HealthQuill
April 10, 2023
0 Comments

India’s Tata Power Company’s distribution arm has signed a pact with ADB for access to debt capital worth INR 1.5 billion ($18.2 million) to increase power supply in the nation’s capital, New Delhi.

Climate Health Pharma

India’s Tata Power secures $20.2 million NCD loan from ADB

HQ Team April 10, 2023: India’s Tata Power Company’s distribution arm has signed a pact with ADB for access to debt capital worth.

by HealthQuill
April 10, 2023
0 Comments

Moderna, a US-based biotechnology company, hopeful of cancer vaccine by 2030

Drugs Health Medical Pharma

Cancer and cardio vaccines will be available by end 2030, says Moderna executive

HQ Team April 8, 2023: Cancer vaccines will be ready by the end of this decade, according to pharmaceutical company Moderna’s chief medical.

by HealthQuill
April 8, 2023
0 Comments

India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and hospital infrastructure as the virus spreads in the South Asian nation.

Health Medical Pharma

India tells states to ramp up COVID-19 emergency procedures

HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.

by HealthQuill
April 8, 2023
0 Comments

The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove its benefits in clinical trials.

Drugs Health Medical Pharma

FDA withdraws approval for Covis’ preterm birth prevention drug

HQ Team April 7, 2023: The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove.

by HealthQuill
April 7, 2023
0 Comments

Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.

Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

by HealthQuill
April 7, 2023
0 Comments

Dengue viral infection has increased from 505,430 cases in 2000 to 5.2 million in 2019, and its spread among humans is increasing globally, the WHO stated

Climate Health Pharma

Dengue viral infections on the rise globally: WHO

HQ Team April 6, 2023: Dengue viral infection has increased from 505,430 cases in 2000 to 5.2 million in 2019, and its spread.

by HealthQuill
April 6, 2023
0 Comments

Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use of its patents in making COVID-19 vaccines.

Drugs Health Medical Pharma

Arbutus drags Pfizer, BioNTech to court over patent infringements

HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.